#Atherectomy & Thromboctomy Devices Market Research Report: Forecast up to 2023
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
In 2020, 44% of users from Denmark used Tumblr daily.
Text
Atherectomy & Thromboctomy Devices Market Research Report: Forecast up to 2023
Atherectomy is one of the important peripheral arterial disease treatment, in which, atherosclerosis from large blood vessels are removed by using minimally invasive surgical approach. In addition, this technique is used for the treatment of coronary arterial diseases. Thromboctomy, also known as pulmonary thromboctomy, is an emergency medical treatment, by which thrombus (blood clot) is removed from arteries and veins. Thromboctomy can be performed by two technologies, by using surgery or by percutaneous techniques. However, surgical thromboctomy technique is used rarely, due to less efficient results and high cost.
Atherectomy technique is a popular substitute for stents and angioplasty treatment. In case of latter, the deposited plaque is pushed inside blood vessel, however, in former, the plaque is removed by using surgical or mechanical technique. This technique has certain advantages over angioplasty and stents, such as, increased wound healing rate, reduction in claudication, reduction in threat of cardiac and other medical complications, less invasive nature, faster patient recovery, high repeatability, ease-of-performance and many others. The device is inserted in the body by making small incision to certain locations of body, such as, common femoral artery, political artery, bronchial artery and others.
The market of Atherectomy devices is segmented on the basis of type and mechanism of device functions, such as, orbital, laser, rotational and directional devices. However, preference of device is based on factors such as, nature and size of plaque, anatomical place to be treated, and surgeon’s expertise. The market for thromboctomy is also segmented on the basis of device type, such as, rotational, ultrasound enhanced and rheolytic thromboctomy devices. In addition, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, the North American region is the most prominent market, owing to increasing technological intervention in cardiac disease management. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in prevalence of cardiac patients and technologies.
View Report-
http://www.transparencymarketresearch.com/atherectomy-thromboctomy-devices-market.html
The market for atherectomy and thromboctomy devices is expected to grow in the upcoming future at a lucrative rate, due to various market drivers, such as rapid increase in the cardiac diseases, changed life-style, increasing preference towards less invasive cardiac disease management practices, less risks involved in the procedure, decreased use of surgical practices for cardiac diseases treatment and technological growth in the development of advanced devices. Rising prevalence of cardiac disorders is one of the most important market driver. According to the U.S. Center for Disease Control and Prevention (CDC), around 0.6 million of Americans die every year due to cardiac diseases, and around 720,000 Americans have a heart attack every year. Further, changed life-style is another contributor for the market growth. Due to consumption of junk food, addiction and lack of exercise, the prevalence of cardiac diseases have been increased and it contributes the market growth of Atherectomy and thromboctomy devices. On the contrary, major restraints that impose hurdles in the market growth include high cost, limited awareness in certain region of the world. Key opportunities include development of cost-effective therapy and strong focus on APAC region (since, India and China possess the largest number of cardiac patients).
Some of the major players operating in the market include Bayer AG, Cardiovascular Systems, Inc., St. Jude Medical Inc., Boston Scientific Corporation, C.R. Bard, inc., Teleflex Medical Inc., and Covidien, Inc. among others.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Atherectomy and Thromboctomy Devices Market during 2015- 2023
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4584
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Atherectomy & Thromboctomy Devices Market Research Report: Forecast up to 2023
Atherectomy is one of the important peripheral arterial disease treatment, in which, atherosclerosis from large blood vessels are removed by using minimally invasive surgical approach. In addition, this technique is used for the treatment of coronary arterial diseases. Thromboctomy, also known as pulmonary thromboctomy, is an emergency medical treatment, by which thrombus (blood clot) is removed from arteries and veins. Thromboctomy can be performed by two technologies, by using surgery or by percutaneous techniques. However, surgical thromboctomy technique is used rarely, due to less efficient results and high cost.
Atherectomy technique is a popular substitute for stents and angioplasty treatment. In case of latter, the deposited plaque is pushed inside blood vessel, however, in former, the plaque is removed by using surgical or mechanical technique. This technique has certain advantages over angioplasty and stents, such as, increased wound healing rate, reduction in claudication, reduction in threat of cardiac and other medical complications, less invasive nature, faster patient recovery, high repeatability, ease-of-performance and many others. The device is inserted in the body by making small incision to certain locations of body, such as, common femoral artery, political artery, bronchial artery and others.
The market of Atherectomy devices is segmented on the basis of type and mechanism of device functions, such as, orbital, laser, rotational and directional devices. However, preference of device is based on factors such as, nature and size of plaque, anatomical place to be treated, and surgeon’s expertise. The market for thromboctomy is also segmented on the basis of device type, such as, rotational, ultrasound enhanced and rheolytic thromboctomy devices. In addition, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, the North American region is the most prominent market, owing to increasing technological intervention in cardiac disease management. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in prevalence of cardiac patients and technologies.
View Report-
http://www.transparencymarketresearch.com/atherectomy-thromboctomy-devices-market.html
The market for atherectomy and thromboctomy devices is expected to grow in the upcoming future at a lucrative rate, due to various market drivers, such as rapid increase in the cardiac diseases, changed life-style, increasing preference towards less invasive cardiac disease management practices, less risks involved in the procedure, decreased use of surgical practices for cardiac diseases treatment and technological growth in the development of advanced devices. Rising prevalence of cardiac disorders is one of the most important market driver. According to the U.S. Center for Disease Control and Prevention (CDC), around 0.6 million of Americans die every year due to cardiac diseases, and around 720,000 Americans have a heart attack every year. Further, changed life-style is another contributor for the market growth. Due to consumption of junk food, addiction and lack of exercise, the prevalence of cardiac diseases have been increased and it contributes the market growth of Atherectomy and thromboctomy devices. On the contrary, major restraints that impose hurdles in the market growth include high cost, limited awareness in certain region of the world. Key opportunities include development of cost-effective therapy and strong focus on APAC region (since, India and China possess the largest number of cardiac patients).
Some of the major players operating in the market include Bayer AG, Cardiovascular Systems, Inc., St. Jude Medical Inc., Boston Scientific Corporation, C.R. Bard, inc., Teleflex Medical Inc., and Covidien, Inc. among others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Atherectomy and Thromboctomy Devices Market during 2015- 2023
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4584
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Atherectomy and Thromboctomy Devices Market To Witness Exponential Growth By 2023
Atherectomy is a key treatment for peripheral arterial disease. The treatment involves the removal of arteriosclerosis from the large blood vessels. The treatment predominantly uses minimally invasive procedures and can also be used for treating coronary arterial diseases. It is a commonly used substitute to angioplasty and arterial stent treatment options. A thromboctomy treatment implies the removal of blood clots from arteries and veins. The two most common procedures for this are surgical or percutaneous.
This report is a comprehensive revision of current trends in The Global Atherectomy And Thromboctomy Devices Market, including its current drivers and restraints. The report delivers market projections for the given forecast period, which includes a thorough analysis of recent expansions in technologies. The report also presents an analysis of the global atherectomy and thromboctomy devices market based on its competitive parameters, through Porter’s five force model analysis and a SWOT analysis. It also analyzes this market on the basis of its current and predicted trends, key regions, and segmentation categories. This report provides comprehensive analysis of the market structure, current market trends, factors limiting market growth, market growth drivers, and the market projections for the given forecast period.
Global Atherectomy and Thromboctomy Devices Market: Trends and Opportunities:
The principle driver for the global atherectomy and thromboctomy devices market currently is the swift rate of increase in the number of cardiac patients in the world. With a greater number of patients demanding modern treatment options for heart problems, the healthcare and medical devices industry needs to pick up the pace in terms of development of better methods and making them available to a greater demographic. With respect to age, the atherectomy and thromboctomy treatments are largely in demand by the elderly, and the geriatric demographic is rising in number at a very strong pace. This is currently one of the chief reasons for the increase in demand.
The global atherectomy and thromboctomy devices market is however, being restrained by high costs of these devices, coupled with a limited awareness regarding the newer treatment options available, especially in the emerging economies of the world. Meanwhile, the future of the global atherectomy and thromboctomy devices market is expected to depend on the release of cheaper and less intensive treatment options.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4584
Global Atherectomy and Thromboctomy Devices Market: Region-wise Outlook:
From a regional perspective, the global atherectomy and thromboctomy devices market can be segmented into the key areas of North America, Asia Pacific, Europe, and the rest of the world. With these regions in mind, the market has so far been dominated by North America, owing to the advanced state of the region’s healthcare and medical devices industries. Additionally, North America holds a very number of patients suffering from chronic diseases and heart complications. The global atherectomy and thromboctomy devices market is likely to continue being directed by North America over the coming years.
However, a booming economic rate of growth, a greater healthcare patient outreach, and the increasing scope of medical tourism is allowing Asia Pacific to lead the global atherectomy and thromboctomy devices market in terms of growth rate, over the given forecast period. A few countries from the regions of Latin America and the MEA are also expected to show a high rate of growth in their demand for atherectomy and thromboctomy treatments and devices.
Companies Mentioned in the Research Report:
The key players mentioned in the report for the global atherectomy and thromboctomy devices market so far, include Bayer AG, Cardiovascular Systems, Inc., St. Jude Medical Inc., Boston Scientific Corporation, C.R. Bard, inc., Teleflex Medical Inc., and Covidien, Inc.
Pre-Book Full Report -
https://www.transparencymarketresearch.com/checkout.php?rep_id=4584<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Link
0 notes